Localization of the binding site for the monocyte immunoglobulin (Ig) A-Fc receptor (CD89) to the domain boundary between Cα2 and Cα3 in human IgA1

Journal of Experimental Medicine

Volumn 183, Issue 4, 1996, Pages 1579-1586

  Carayannopoulos, Leonidas ^a   Hexham, J Mark ^b   Capra, J Donald ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN A1; RECOMBINANT PROTEIN;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; BACULOVIRUS; BINDING SITE; HUMORAL IMMUNITY; INFLAMMATORY CELL; INSECT; MONOCYTE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; VIRUS RECOMBINANT;

AMINO ACID SEQUENCE; ANTIGENS, CD; BINDING SITES; HUMANS; IMMUNOGLOBULIN A; MOLECULAR SEQUENCE DATA; MONOCYTES; POINT MUTATION; RECEPTORS, FC; RECOMBINANT FUSION PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0029924133     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.4.1579     Document Type: Article

References (48)

1. Mestecky, J., and J.R. McGhee. 1987. IgA: molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv. Immunol. 40:153-245.
2. Weisbart, R.H., A. Kacena, A. Schuh, and D.W. Golde. 1988. GM-CSF induces human neutrophil-mediated phagocytosis by an IgA Fc receptor activation mechanism. Nature. (Lond.). 332:647-648.
3. Monteiro, R.C., R.W. Hostoffer, M.D.Cooper, J.R. Bonner, G.L. Gartland, and H. Kubagawa. 1993. Definition of IgA receptors on eosinophils and their enhanced expression in allergic individuals. J. Clin. Invest. 92:1681-1685.
4. Shen, L., R. Lasser, and M.W. Fanger. 1989. My43, A monoclonal antibody that reacts with human myeloid cells inhibits monocyte IgA binding and triggers function. J. Immunol. 143:4117-4122.
5. Lucisano-Valim, Y.M., and P.J. Lachmann. 1991. The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systematic study using chimeric anti-NP antibodies with human Fc regions. Clin. Exp. Immunol. 84:1-8.
6. Mostov, K.E., M. Fnedlander, and G. Blobel. 1984. The receptor for transepithelial transport of IgA and IgM contains multiple immunoglobulin-like domains. Nature (Lond.). 308: 37-43.
7. Maliszewski, C.R., C.J. March, M.A. Schoenborn, S. Gimpel, and L. Shen. 1990. Expression cloning of a human Fc receptor for IgA. J. Exp. Med. 172:1665-1672.
8. Carayannopoulos, L., E.E. Max, and J. D. Capra. 1994. Recombinant human IgA expressed in insect cells. Proc. Natl. Acad. Sci. USA. 91:8348-8352.
9. Canfield, S.M., and S.L. Morrison. 1991. The binding affinity of human IgG for its high affinity Fc receptor is determined by multiple amino acids in the CH2 domain and is modulated by the hinge region. J. Exp. Med. 173:1483-1491.
10. Chappel, M.S., D.E. Isenman, M. Everett, Y.-Y. Xu, K.J. Dorrington, and M.H. Klein. 1991. Identification of the Fcγ receptor class I binding site in human IgG through the use of recombinant IgG1/IgG2 hybrid and point-mutated antibodies. Proc. Natl. Acad. Sci. USA. 88:9036-9040.
11. Sarmay, G., J. Lund, Z. Rozsnyay, J. Gergely, and R. Jefferis. 1992. Mapping and comparison of the interaction sites on the Fc region of IgG responsible for triggering antibody dependent cellular cytotoxicity (ADCC) through different types of human Fcγ receptor. Mol. Immunol. 29:633-639.
12. Nissim, A., and Z. Eshhar. 1992. The human mast cell receptor binding site maps to the third constant domain of immunoglobulin E. Mol. Immunol. 9:1065-1072.
13. Burton, D.R., and J.M. Woof. 1992. Human antibody effector function. Adv. Immunol. 51:1-84.
14. Hasemann, C.A., and J.D. Capra. 1990. High-level production of a functional immunoglobulin heterodimer in a baculovirus expression system. Proc. Natl. Acad. Sci. USA 87: 3942-3946.
15. Tuaillon, N., L.D. Taylor, N. Lonberg, P.W. Tucker, and J.D. Capra. 1993. Human immunoglobulin heavy chain minilocus recombination in transgenic mice: gene segment use in mu and gamma transcripts. Proc. Natl. Acad. Sci. USA. 90:3720-3724.
16. Horton, R.M., Z. Cai, S.N. Ho, and L.R. Pease. 1990. Gene splicing by overlap extension: tailor-made genes using the polymerase chain reaction. Biotechniques. 8:528-535.
17. Kabat, E.A., T.T. Wu, H.M. Perry, K.S. Gottesman, and C. Foeller. 1991. Sequences of Proteins of Immunologic Interest. U.S. Department of Health and Human Services, Washington DC. 2597 pp.
18. Sambrook, J., E.F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spnng Harbor, NY.
19. O'Reilly, D.R., L.K. Miller, and V.A. Luckow. 1992. Baculovirus Expression Vectors: A Laboratory Manual. W.H. Freeman and Company, New York. 347 pp.
20. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.) 227:680-685.
21. Biewenga, J., A. Faber, G. de Lange, F. van Leeuwen, P. van Eede, R. Jefferis, J.J. Haaijman, and A. Vlug. 1986. Monoclonal antibodies against different domains of human IgA: specificities determined by immunoblotting and haemagglutination-inhibition. Mol. Immunol. 23:761-767.
22. Collins, S.J., R.C. Gallo, and R.E. Galagher. 1977. Continuous growth and differentiation of human myeloid leukemic cells in suspension culture. Nature (Lond.). 270:347-349.
23. Baker, P.E., and K.F. Knoblock. 1982. Bovine costimulator. I. Production, partial purification, and quantification in serum-free Iscove's medium. Vet. Immunol. Immunopathol. 3: 365-379.
24. Rigby, W.F.C., L. Shen, E.D. Ball, and M.W. Fanger. 1985. 1,25 dihydroxyvitamin D3 induces a myelomonocytic phenotype with enhanced effector cell function in the HL-60 promyelocytic leukemia cell line. Mol. Immunol. 22: 567-572.
25. Henry, C. 1980. Anti-hapten placques. In Selected Methods in Cellular Immunology. B.B. Mishell and S.M. Shiigi, editors. W.H. Freeman and Company, San Francisco. 95-98.
26. Prahl, J.W., C.A. Abel, and H. M. Grey. 1971. Carboxy-terminal structure of the α chain of human IgA myeloma proteins. Biochemistry. 10:1808-1812.
27. Deisenhofer, J., T.A. Jones, R. Huber, J. Sjodahl, and J. Sjoquist. 1978. Crystallization, crystal structure analysis and atomic model of the complex formed by a human Fc fragment and fragment B of protein A from Staphylococcus aureus. Hoppe-Seyler's Z. Physiol. Chem. 359:975-985.
28. Deisenhofer, J. 1981. Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-Å resolution. Biochemistry. 20:2361-2370.
29. Zheng, X.X., A.W. Steele, P.W. Nickerson, W. Steurer, J. Steiger, and T.B. Strom. 1995. Administration of noncytolytic IL-10/Fc in murine models of lipopolysaccharide-induced septic shock and allogeneic islet transplantation. J. Immunol. 154:5590-5600.
30. Weetall, M., B. Shopes, D. Holowka, and B. Baird. 1990. Mapping the site of interaction between murine IgE and its high afinity receptor with chimeric Ig. J. Immunol. 145:3849-3854.
31. Pantoliano, M.W., R.E. Bird, S. Johnson, E.D. Asel, S.W. Dodd, J.F. Wood, and K.D. Hardmann. 1991. Conformational stability, folding, and ligand-binding of single-chain Fv immunoglobulin fragments expressed in Escherichia coli. Biochemistry. 30:10117-10125.
32. Edmundson, A.B., K.R. Ely, E.E. Abola, M. Schiffer, and N. Panagiatopoulos. 1975. Rotational allomerism and divergent evolution of domains in immunoglobulin light chains. Biochemistry. 14:3953-3961.
33. Lesk, A.M., and C. Chothia. 1982. Evolution of proteins formed by β-sheets II. The core of the immunoglobulin domains. J. Mol. Biol. 160:325-342.
34. Kim, J.-K., M.-F. Tsen, V. Ghetie, and E.S. Ward. 1994. Localization of the site of the murine IgG1 molecule that is involved in binding to the murine intestinal Fc receptor. Eur. J. Immunol. 24:2429-2434.
35. Kim, J.-K., M.-F. Tsen, V. Ghetie, and E.S. Ward. 1994. Identifying amino acid residues that influence plasma clearance of murine IgG1 fragments by site-directed mutagenesis. Eur. J. Immunol 24:542-548.
36. Simister, N.E., and K.E. Mostov. 1989. An Fc receptor structurally related to MHC class I antigens. Nature (Lond.) 337: 184-187.
37. Kremer, K.J., V. Kalatzis, E. Baker, D.F. Callen, G.R. Sutherland, and C.R. Maliszewski. 1992. The gene for human IgA receptor maps to 19q13.4. Hum. Genet. 89:107-108.
38. Fellah, J.S., F. Kerfourn, M.V. Wiles, J. Schwager, and J. Charlemagne. 1993. Phylogeny of immunoglobulin heavy chain isotypes: structure of the constant region of Ambystoma mexicanum υ chain deduced from cDNA sequence. Immunogenetics. 38:311-317.
39. Hill, R.L., R. Delaney, R.E. Fellows, and H.E. Lebovitz. 1966. The evolutionary history of the immunoglobulins. Proc. Natl. Acad. Sci. USA. 56:1762-1769.
40. Kilian, M., J. Mestecky, and M.W. Russell. 1988. Defense mechanisms involving Fc-dependent functions of IgA and their subversion by bacterial IgA proteases. Microbiol Rev. 52: 296-303.
41. Underdown, B.J., and J.M. Schiff. 1986. Immunoglobulin A: strategic defense initiative at the mucosal surface. Annu. Rev. Immunol. 4:389-417.
42. Plaut, A.G., and W.W. Bachovchin. 1994. IgA-specific prolyl endopeptidases (serine-type). Methods Enzymol. 244:137-151.
43. Plaut, A.G., and A. Wright. 1995. IgA-specific prolyl endopeptidases (metallo-type). Methods Enzymol. 248:634-642.
44. Kawamura, S., and S. Ueda. 1992. Immunoglobulin CH gene family in hominoids and its evolutionary history. Genomics. 13:194-200.
45. Plaut, A.G., R. Wistar, and J D. Capra. 1974. Differential susceptibility of human IgA immunoglobulins to streptococcal IgA protease. J. Clin. Invest. 54:1295-1300.
46. van Loghem, E., and G. de Lange. 1979. Immunoglobulin epitopes in primates. Vox Sang. 37:329-337.
47. Fujiyama, Y., K. Kobayashi, S. Senda, Y. Benno, T. Bamba, and S. Hosoda. 1985. A novel IgA protease from Clostridium spp. capable of cleaving IgA1 and IgA2 A2m(1) allotype but not IgA2 A2m(2) allotype paraproteins. J. Immunol. 134:573-576.
48. Klein, M., N. Haeffner-Cavaillon, D.E. Isenman, C. Rivat, M.A. Navia, M.A. Davies, and K.J. Dorrington. 1981. Expression of biological effector functions by immunoglobulin G molecules lacking the hinge region. Proc. Natl. Acad. Sci USA. 78:524-528.